AusHSI is working with the Australian Translational Genomics Centre (ATGC) to evaluate the cost-effectiveness of next-generating sequencing to inform clinical decision making in blood cancer.
Launched in July last year, the ATGC is led by QUT Professor Matt Brown in partnership with Pathology Queensland and Metro South Hospital and Health Service. It is the first genomic diagnostic service in Queensland to provide whole-exome sequencing for cancer patients. The technology is being used to identify actionable genetic mutations not covered by current genetic testing, to inform individual treatment decisions and avoid procedures that are unlikely to be effective.
The full press release from QUT media can be read at this link.